United Biomedical   Report issue

For profit Phase 1 Phase 2
Founded: Hauppauge NY United States (1983)
Status: Left NME R&D (2018)

Organization Overview

First Clinical Trial
1999
NCT00002428
First Marketed Drug
2013
terbutaline (bricanyl)
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

UBI Asia in Taiwan | UNITED BIOMEDCL | United Biomedical | United Biomedical Inc., Asia